Effectiveness and safety of rivaroxaban versus warfarin in Taiwanese patients with end-stage renal disease and nonvalvular atrial fibrillation: A real-world nationwide cohort study

BACKGROUND: The optimal anticoagulant for end-stage renal disease patients for stroke prophylaxis is unknown. The efficacy and safety of warfarin in this population are debatable. In addition, real-world evidence of direct oral anticoagulants in patients with end-stage renal disease is limited. The...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PLoS One
Hauptverfasser: Lin, Yi-Cheng, Chen, Bi-Li, Shih, Chun-Ming, Lin, Feng-Yen, Chen, Chih-Wei, Hsu, Chien-Yi, Kao, Yung-Ta, Bi, Wei-Fung, Chen, Li-Ying, Chien, Li-Nien, Fang, Te-Chao, Huang, Chun-Yao
Format: Artigo
Sprache:Inglês
Veröffentlicht: Public Library of Science 2021
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8031437/
https://ncbi.nlm.nih.gov/pubmed/33831130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0249940
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge